Adham S. Bear, MD, PhD

Adham Bear received a combined MD and PhD degree from Baylor College of Medicine in 2013 before completing a residency training program in Internal Medicine at the Johns Hopkins Hospital. He performed his clinical fellowship training in Hematology and Oncology at the Hospital of the University of Pennsylvania, where he is now an Instructor of Medicine. 

Dr. Bear’s research interests focus within the field of cancer immunotherapy, specifically tumor antigen discovery, cancer vaccination, adoptive T cell therapy, and T cell engineering/gene-editing. Dr. Bear has experience working in multi-disciplinary settings consisting of scientists and physicians to translate laboratory discoveries to the clinic. As a faculty member at the University of Pennsylvania, he conducts clinical and translational research projects to develop oncogene-targeted immune therapies for cancer patients.

Dr. Bear’s current research interest explores the immunologic targeting of somatic mutations within the RAS proto-oncogene family to develop TCR therapies for cancer patients.